Healthcare giants UnitedHealth Group and Johnson & Johnson reported Q3 results on Tuesday, with both raising their full-year earnings outlooks but delivering contrasting reports.
UnitedHealth tops Q3 earnings estimates as lower medical costs and improved margins boost EPS 60.6%, prompting management to raise its 2026 earnings outlook.
UnitedHealth Group Incorporated delivered Q3 2026 beats on both top and bottom lines, raising full-year guidance and reaffirming a fundamental turnaround under new management. UNH's margin profile is improving, with MCR and OCR both better than expected, driven by shedding unprofitable businesses and focusing on efficiency and technology investment. Shareholder returns remain robust, combining a forward dividend yield of 2.48% and significant buybacks for a total yield near 5%, supported by strong cash generation.
UnitedHealth Group NYSE: UNH reported third-quarter 2026 revenue of $113 billion and adjusted earnings per share of $4.69, compared with $2.92 a year earlier, as the healthcare company cited improving execution across UnitedHealthcare and Optum.
Although the revenue and EPS for UnitedHealth (UNH) give a sense of how its business performed in the quarter ended September 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
UnitedHealth Group Inc (NYSE:UNH, XETRA:UNH), the US healthcare group, raised its 2026 earnings outlook after third-quarter operating earnings increased 52% to $6.6 billion, supported by lower medical costs and improved operational performance. The company now expects adjusted earnings of at least $20.50 a share for 2026, up from $18.15 in 2025, following results that exceeded the previous year's performance.
UnitedHealth Group shares are on the rise after a better-than-expected earnings report.
UnitedHealth Group (NYSE:UNH | UNH Price Prediction) shares are up 4% to $395.19 after the health insurer topped Q3 2026 profit estimates and raised its full-year outlook.
UnitedHealth Group Incorporated delivered a strong Q3 double beat, with EPS 13% above consensus and clear margin improvement. UNH's turnaround strategy—shedding unprofitable patient groups and focusing on cost control—drove net margin expansion from 2.1% to 3.6%. Management raised 2026 EPS guidance to at least $20.50, reflecting confidence in ongoing profitability improvements.
Big bank earnings are in focus as third-quarter earnings season kicks off, but several other major names are reporting results as well.
UnitedHealth Group (UNH) came out with quarterly earnings of $4.69 per share, beating the Zacks Consensus Estimate of $4.12 per share. This compares to earnings of $2.92 per share a year ago.
AI stocks drop as investors lock in some profit ahead of earnings season while UnitedHealth rallies following strong third-quarter earnings.